Literature DB >> 26435083

The role of S100 proteins and their receptor RAGE in pancreatic cancer.

Estelle Leclerc1, Stefan W Vetter2.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with low survival rates. Current therapeutic treatments have very poor response rates due to the high inherent chemoresistance of the pancreatic-cancer cells. Recent studies have suggested that the receptor for advanced glycation end products (RAGE) and its S100 protein ligands play important roles in the progression of PDAC. We will discuss the potential role of S100 proteins and their receptor, RAGE, in the development and progression of pancreatic cancer.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Pancreatic ductal adenocarcinoma; RAGE; S100 proteins

Year:  2015        PMID： 26435083      PMCID： PMC4643662          DOI： 10.1016/j.bbadis.2015.09.022

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


  49 in total

1.  RAGE: a single receptor fits multiple ligands.

Authors:  Günter Fritz
Journal:  Trends Biochem Sci       Date:  2011-10-19       Impact factor: 13.807

2.  RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer.

Authors:  Joseph DiNorcia; Minna K Lee; Dorota N Moroziewicz; Megan Winner; Paritosh Suman; Fei Bao; Helen E Remotti; Yu Shan Zou; Shi Fang Yan; Wanglong Qiu; Gloria H Su; Ann Marie Schmidt; John D Allendorf
Journal:  J Gastrointest Surg       Date:  2011-11-04       Impact factor: 3.452

3.  In vivo antitumor effect of cromolyn in PEGylated liposomes for pancreatic cancer.

Authors:  Cha-Eun Kim; Sun-Kyung Lim; Jin-Seok Kim
Journal:  J Control Release       Date:  2011-09-16       Impact factor: 9.776

4.  Interaction between S100P and the anti-allergy drug cromolyn.

Authors:  Srinivasa R Penumutchu; Ruey-Hwang Chou; Chin Yu
Journal:  Biochem Biophys Res Commun       Date:  2014-10-17       Impact factor: 3.575

Review 5.  S100 proteins in cancer.

Authors:  Anne R Bresnick; David J Weber; Danna B Zimmer
Journal:  Nat Rev Cancer       Date:  2015-02       Impact factor: 60.716

6.  Altered intracellular calcium fluxes in pancreatic cancer induced diabetes mellitus: Relevance of the S100A8 N-terminal peptide (NT-S100A8).

Authors:  Daniela Basso; Eliana Greco; Andrea Padoan; Paola Fogar; Michele Scorzeto; Elisa Fadi; Dania Bozzato; Stefania Moz; Filippo Navaglia; Carlo-Federico Zambon; Roberta Seraglia; Eugenio De Carlo; Anna Valerio; Carlo Reggiani; Sergio Pedrazzoli; Mario Plebani
Journal:  J Cell Physiol       Date:  2011-02       Impact factor: 6.384

7.  Orai1 and STIM1 mediate SOCE and contribute to apoptotic resistance of pancreatic adenocarcinoma.

Authors:  Kateryna Kondratska; Artem Kondratskyi; Maya Yassine; Loic Lemonnier; Gilbert Lepage; Angela Morabito; Roman Skryma; Natalia Prevarskaya
Journal:  Biochim Biophys Acta       Date:  2014-02-26

8.  Analyzing S100A6 expression in endoscopic ultrasonography-guided fine-needle aspiration specimens: a promising diagnostic method of pancreatic cancer.

Authors:  Guo Zihao; Zhang Jie; Liang Yan; Zhang Jing; Chen Jing; Li Xue; Zhu Jing; Li Wing Heng; Gao Ru; Hao Jianyu
Journal:  J Clin Gastroenterol       Date:  2013-01       Impact factor: 3.062

9.  Identification, classification, and expression of RAGE gene splice variants.

Authors:  Barry I Hudson; Angela M Carter; Evis Harja; Anastasia Z Kalea; Maria Arriero; Hojin Yang; Peter J Grant; Ann Marie Schmidt
Journal:  FASEB J       Date:  2007-12-18       Impact factor: 5.191

Review 10.  Joining S100 proteins and migration: for better or for worse, in sickness and in health.

Authors:  Stephane R Gross; Connie Goh Then Sin; Roger Barraclough; Philip S Rudland
Journal:  Cell Mol Life Sci       Date:  2013-06-30       Impact factor: 9.261
View more
  30 in total

1.  Solving the crystal structure of human calcium-free S100Z: the siege and conquer of one of the last S100 family strongholds.

Authors:  V Calderone; M Fragai; G Gallo; C Luchinat
Journal:  J Biol Inorg Chem       Date:  2017-01-10       Impact factor: 3.358

Review 2.  Hypoxia driven glycation: Mechanisms and therapeutic opportunities.

Authors:  Mohammad Imran Khan; Suvasmita Rath; Vaqar Mustafa Adhami; Hasan Mukhtar
Journal:  Semin Cancer Biol       Date:  2017-05-22       Impact factor: 15.707

3.  Co-expression of High-mobility group box 1 protein (HMGB1) and receptor for advanced glycation end products (RAGE) in the prognosis of esophageal squamous cell carcinoma.

Authors:  Lingzhao Li; Narasimha M Beeraka; Linsen Xie; Li Dong; Junqi Liu; Lei Wang
Journal:  Discov Oncol       Date:  2022-07-13

4.  The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.

Authors:  Kota Araki; Rie Kinoshita; Nahoko Tomonobu; Yuma Gohara; Shuta Tomida; Yuta Takahashi; Satoru Senoo; Akihiko Taniguchi; Junko Itano; Ken-Ichi Yamamoto; Hitoshi Murata; Ken Suzawa; Kazuhiko Shien; Hiromasa Yamamoto; Mikio Okazaki; Seiichiro Sugimoto; Kouichi Ichimura; Masahiro Nishibori; Nobuaki Miyahara; Shinichi Toyooka; Masakiyo Sakaguchi
Journal:  J Mol Med (Berl)       Date:  2020-11-09       Impact factor: 4.599

Review 5.  Neutrophils in Tumorigenesis: Missing Targets for Successful Next Generation Cancer Therapies?

Authors:  Fabrice Tolle; Viktor Umansky; Jochen Utikal; Stephanie Kreis; Sabrina Bréchard
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

6.  S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain.

Authors:  Md Imran Khan; Yu-Kai Su; Jinhao Zou; Lee-Wei Yang; Ruey-Hwang Chou; Chin Yu
Journal:  PLoS One       Date:  2018-02-14       Impact factor: 3.240

7.  Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression.

Authors:  Max H Kushner; Virginie Ory; Garrett T Graham; Ghada M Sharif; William B Kietzman; Sophia Thevissen; Meng Yuan; Marcel O Schmidt; Anton Wellstein; Anna T Riegel
Journal:  EMBO Rep       Date:  2019-12-02       Impact factor: 8.807

Review 8.  The Role of miRNAs in the Regulation of Pancreatic Cancer Stem Cells.

Authors:  Sabrina Bimonte; Antonio Barbieri; Maddalena Leongito; Giuseppe Palma; Vitale Del Vecchio; Michela Falco; Raffaele Palaia; Vittorio Albino; Mauro Piccirillo; Alfonso Amore; Antonella Petrillo; Vincenza Granata; Francesco Izzo
Journal:  Stem Cells Int       Date:  2016-02-24       Impact factor: 5.443

Review 9.  HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins.

Authors:  Damien Bertheloot; Eicke Latz
Journal:  Cell Mol Immunol       Date:  2016-08-29       Impact factor: 11.530

Review 10.  LncRNAs in pancreatic cancer.

Authors:  Xiaoyi Huang; Xiaosong Zhi; Yisha Gao; Na Ta; Hui Jiang; Jianming Zheng
Journal:  Oncotarget       Date:  2016-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.